vorasidenib

US, EU regulators start swift reviews of Servier glioma drug
Pharmaphorum
Wed, 02/21/24 - 11:09 am
FDA
EMA
Servier
vorasidenib
glioma
brain cancer
Servier’s vorasidenib proves efficacy in tumor growth reduction
Clinical Trials Arena
Mon, 11/20/23 - 10:09 am
Servier
vorasidenib
glioma
clinical trials
ASCO: French Pharma's Drug Slows Tumors in Brain Cancer Patients
BioSpace
Mon, 06/5/23 - 10:00 pm
ASCO 2023
Servier
glioma
vorasidenib
Agios up as FDA gives Thermo Fisher glioma test breakthrough status
Pharmaforum
Tue, 06/16/20 - 10:35 am
Agios Pharmaceuticals
FDA
vorasidenib
brain cancer
glioma